Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
2023-03-20 4:55 pm Purchase | 13G | Pliant Therapeutics, Inc. PLRX | Deep Track Capital LP | 3,104,507 5.27% | 3,104,507![]() (New Position) | View |
2023-03-20 4:43 pm Purchase | 13G | Orchard Therapeutics plc ORTX | Deep Track Capital LP | 19,125,150 9.99% | 19,125,150![]() (New Position) | View |
2023-02-24 4:13 pm Purchase | 13G | Nurix Therapeutics, Inc. NRIX | Deep Track Capital LP | 2,717,171 5.75% | 450,602![]() (+19.88%) | View |
2023-02-14 09:53 am Sale | 13G | Keros Therapeutics, Inc. KROS | Deep Track Capital LP | 0 0% | -1,300,000![]() (Position Closed) | View |
2023-02-14 08:59 am Purchase | 13G | Viridian Therapeutics, Inc. VRDN | Deep Track Capital LP | 3,312,974 7.93% | 1,493,285![]() (+82.06%) | View |
2023-02-14 08:59 am Purchase | 13G | Travere Therapeutics, Inc. TVTX | Deep Track Capital LP | 4,582,000 7.14% | 1,146,800![]() (+33.38%) | View |
2023-02-14 08:58 am Sale | 13G | Tricida, Inc. TCDA | Deep Track Capital LP | 4,666,666 7.44% | -1,191,163![]() (-20.33%) | View |
2023-02-14 08:57 am Purchase | 13G | Repare Therapeutics Inc. RPTX | Deep Track Capital LP | 2,727,606 6.5% | 627,606![]() (+29.89%) | View |
2023-02-14 08:56 am Purchase | 13G | Relmada Therapeutics, Inc. RLMD | Deep Track Capital LP | 2,837,818 9.43% | 356,818![]() (+14.38%) | View |
2023-02-14 08:53 am Sale | 13G | Passage Bio, Inc. PASG | Deep Track Capital LP | 0 0% | -3,216,997![]() (Position Closed) | View |
2023-02-14 08:52 am Sale | 13G | Nuvation Bio Inc. NUVB | Deep Track Capital LP | 8,221,188 3.76% | -3,250,093![]() (-28.33%) | View |
2023-02-14 08:50 am Sale | 13G | Nurix Therapeutics, Inc. NRIX | Deep Track Capital LP | 2,266,569 4.81% | -169,595![]() (-6.96%) | View |
2023-02-14 08:50 am Sale | 13G | Nkarta, Inc. NKTX | Deep Track Capital LP | 1,354,200 2.77% | -611,484![]() (-31.11%) | View |
2023-02-14 08:47 am Sale | 13G | Magenta Therapeutics, Inc. MGTA | Deep Track Capital LP | 3,000,000 4.95% | -1,870,000![]() (-38.40%) | View |
2023-02-14 08:45 am Sale | 13G | Madrigal Pharmaceuticals, Inc. MDGL | Deep Track Capital LP | 0 0% | -917,825![]() (Position Closed) | View |
2023-02-14 08:44 am Sale | 13G | Kura Oncology, Inc. KURA | Deep Track Capital LP | 0 0% | -3,362,000![]() (Position Closed) | View |
2023-02-14 08:42 am Purchase | 13G | Chinook Therapeutics, Inc. KDNY | Deep Track Capital LP | 3,000,000 4.69% | 247,930![]() (+9.01%) | View |
2023-02-14 08:41 am Sale | 13G | KalVista Pharmaceuticals, Inc. KALV | Deep Track Capital LP | 0 0% | -1,500,000![]() (Position Closed) | View |
2023-02-14 08:40 am Purchase | 13G | Jounce Therapeutics, Inc. JNCE | Deep Track Capital LP | 4,259,653 8.24% | 259,653![]() (+6.49%) | View |
2023-02-14 08:39 am Sale | 13G | IVERIC bio, Inc. ISEE | Deep Track Capital LP | 7,878,119 5.88% | -1,121,881![]() (-12.47%) | View |